Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study

Multiple sclerosis (MS) is a chronic and demyelinating disease with an autoimmune origin, which leads to neurodegeneration and progressive disability. Approximately 30 to 50% of patients do not respond optimally to disease-modifying therapies (DMTs), and therapeutic response may be influenced by gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Gaitan, Esteban Alejandro, Garcia-Ortega, Yessica Eleanet, Saldaña-Cruz, Ana Miriam, Contreras-Haro, Betsabe, Gamez-Nava, Jorge Ivan, Perez-Guerrero, Emilio Edsaul, Nava-Valdivia, Cesar Arturo, Gallardo-Moya, Sergio, Martinez-Hernandez, Alejandra, Gonzalez Lopez, Laura, Rios-Gonzalez, Blanca Esthela, Marquez-Pedroza, Jazmin, Mendez-del Villar, Miriam, Esparza-Guerrero, Yussef, Villagomez-Vega, Alejandra, Macias Islas, Miguel Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572793/
https://www.ncbi.nlm.nih.gov/pubmed/37834042
http://dx.doi.org/10.3390/ijms241914594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572793/
https://www.ncbi.nlm.nih.gov/pubmed/37834042
http://dx.doi.org/10.3390/ijms241914594

Ejemplares similares